Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galbraith

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
Disease Markers|October 1, 1988
Group specific component (Gc) and HIV diseasesD F Rosberger, P A Werner, R Steinman, et al.
British Medical Journal|June 19, 1976
Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal diseaseR M Galbraith, N el Sheikh, B Portmann, et al.
Circulatory Shock|July 1, 1989
Alterations in Gc levels and complexing in septic shockW M Lee, D Reines, G H Watt, et al.
Lancet (London, England)|May 1, 1976
Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shuntingR M Galbraith, A L Eddleston, R Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Reaction of T lymphocytes with anti-T3 induces translocation of C-kinase activity to the membrane and specific substrate phosphorylationA E Nel, P Bouic, G R Lattanze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1985
Phorbol ester induces tyrosine phosphorylation in normal and abnormal human B lymphocytesA E Nel, M Navailles, D F Rosberger, et al.
Optics Letters|November 1, 2014
Automatic laser welding and milling with in situ inline coherent imagingP J L Webster, L G Wright, Y Ji, et al.
The Journal of Clinical Investigation|May 1, 1988
Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbitP J Goldschmidt-Clermont, H Van Baelen, R Bouillon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2003
Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic resultsGordon J S Rustin, Susan M Galbraith, Helen Anderson, et al.
NMR in Biomedicine|March 1, 2002
Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysisSusan M Galbraith, Martin A Lodge, N Jane Taylor, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
Disease Markers|October 1, 1988
Group specific component (Gc) and HIV diseasesD F Rosberger, P A Werner, R Steinman, et al.
British Medical Journal|June 19, 1976
Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal diseaseR M Galbraith, N el Sheikh, B Portmann, et al.
Circulatory Shock|July 1, 1989
Alterations in Gc levels and complexing in septic shockW M Lee, D Reines, G H Watt, et al.
Lancet (London, England)|May 1, 1976
Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shuntingR M Galbraith, A L Eddleston, R Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Reaction of T lymphocytes with anti-T3 induces translocation of C-kinase activity to the membrane and specific substrate phosphorylationA E Nel, P Bouic, G R Lattanze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1985
Phorbol ester induces tyrosine phosphorylation in normal and abnormal human B lymphocytesA E Nel, M Navailles, D F Rosberger, et al.
Optics Letters|November 1, 2014
Automatic laser welding and milling with in situ inline coherent imagingP J L Webster, L G Wright, Y Ji, et al.
The Journal of Clinical Investigation|May 1, 1988
Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbitP J Goldschmidt-Clermont, H Van Baelen, R Bouillon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2003
Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic resultsGordon J S Rustin, Susan M Galbraith, Helen Anderson, et al.
NMR in Biomedicine|March 1, 2002
Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysisSusan M Galbraith, Martin A Lodge, N Jane Taylor, et al.
Pageof 23